Clinical Trial Update: VENICE Study Nevirapine Full Dose/Dose Escalation [Phase 4]

View source ↗

Summary

The VENICE Phase 4 trial evaluated full-dose versus dose-escalation nevirapine regimens in HIV-infected participants; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Clinical Trial Agency of HIV Study Group | Conditions: HIV Infections | Phase 4 | Status: COMPLETED